Elite Pharmaceuticals, Inc. Cash
Elite Pharmaceuticals, Inc. (ELTP) had Cash of $38.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2026-08-13
- 2026-06-30: Cash $38.94M.
- 2026-03-31: Cash $29.80M.
- 2025-12-31: Cash $21.09M.
- 2025-09-30: Cash $26.62M.
| Period end | Cash |
|---|---|
| 2026-06-30 | $38.94M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $29.80M 10-Q · filed 2026-08-13 |
| 2025-12-31 | $21.09M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $26.62M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $21.74M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $11.32M 10-K · filed 2026-06-29 |
| 2024-12-31 | $8.29M 10-Q · filed 2026-02-17 |
| 2024-09-30 | $9.55M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $8.41M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $7.11M 10-K · filed 2025-06-30 |
| 2023-12-31 | $5.82M 10-Q · filed 2025-02-13 |
| 2023-09-30 | $8.65M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $9.08M 10-Q · filed 2024-08-14 |